FDA … 20 Diseases Being Chosen for PDUFA-V Meetings
Last Thursday, October 25th, I attended the FDA’s Patient-Focused Drug Development public meeting in Washington, DC. This meeting was required by the recently passed FDASIA/PDUFA-V legislation (see Abbreviation Decoder at end of post) and requires the FDA to hold 20 disease-specific meetings over the next 5 years to discuss topics such as: “the impact of the disease on patients, […]
FDA … 20 Diseases Being Chosen for PDUFA-V Meetings Read More »